Meet Giriraj Ratan Chandak, the scientist-cum-startup founder who serves through science
I have had a deeply satisfying career at the Centre for Cellular and Molecular Biology. Yet, for a physician and scientist, the journey never truly ends. I realised there were many unfinished goals I still wished to pursue. To carry that vision forward, I founded a startup called Lightening Lives LLP.
As the name suggests, the ethos is to 'light a lamp' in people's lives — whether by addressing genetic disorders, improving health, enabling treatments, or bringing hope in any possible way. Through this startup, our objective is to develop very simple, rapid, and affordable tests that can reach the most underserved sections of society. My years of work in genetic testing have confirmed that we are still only scratching the surface; with traditional approaches, barely 3–5% of patients undergo testing. The situation has only become more pressing with the rise of large-scale, high-throughput genetic testing, which often remains inaccessible to those who need it most.
At Lightening Lives LLP, we decided to focus on 'commonly occurring rare diseases' such as thalassaemia, sickle cell anaemia, and muscular dystrophy, using simple, robust protocols. I am proud to say that along with CSIR-CCMB, we have developed a test for sickle cell anaemia that requires just a drop of blood and costs less than ₹100, making it possible to bring accurate diagnosis directly to the communities that need it most. We are on the path for doing the same for beta thalassemia.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
8 hours ago
- The Hindu
Nemom block panchayat eyes technology tie-up to remove water hyacinth from Vellayani Lake
The Nemom block panchayat is eyeing a tie-up with the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) for removing the invasive water hyacinth from the Vellayani freshwater lake in Thiruvananthapuram district. The proposal involves extracting fibres from water hyacinth for the manufacture of value-added products, which would serve as a means of livelihood for the economically-weaker sections in the locality. The idea was mooted at the Block Innovation Cluster meeting held at the Centre for Human Resource Development, a regional centre of the Kerala Institute of Local Administration at Kottarakara, earlier this week. Though water hyacinth is a weed, the fibre extracted from it can be very useful as a natural fibre. At the meeting, the Nemom block panchayat was entrusted with the task of coordinating the activity with technical support from the CSIR-NIIST. A cottage industry based on the hyacinth fibres offers employment opportunities, especially women, according to the block panchayat. 'Large-scale invasion of water hyacinth has been a major problem in the freshwater lake for years. Though the panchayat has had schemes in the past, a sustainable solution continues to remain elusive,' Ajaighosh P.R., Block Development Officer, Nemom, said. R.S. Praveen Raj, senior principal scientist, represented the CSIR-NIIST at the block Innovation cluster meeting. To extract the fibres, a technology called 'closed retting' has been proposed. It eliminates the pollution-related issues and produces good quality fibre in a short period. An added advantage is that it recovers biogas as an additional resource. Also, the waste material produced in this process can be used as a soil conditioner.
Time of India
2 days ago
- Time of India
From Independence to Innovation: How India and Genomics Grew Together
The 1940s saw the beginning of two remarkable stories. First is India's independence in 1947, and second, the pioneering science of genomics in 1944. Over the past eight decades, India's development and the evolution of genomics have reflected each other's spirit, deeply rooted in developing indigenous capabilities, driven by innovation, and inspired by the vision of a better India. Although DNA was discovered in the latter half of the 19th century, when Friedrich Miescher isolated the hereditary material that was later understood to be DNA, the attempt to decode it was made only in 1944 – when Oswald Avery, Colin MacLeod, and Maclyn McCarty demonstrated its role as carrier of genetic information, laying the foundation for the genomic era. The 1950s & 60s witnessed India's investment in building expertise, with the establishment of CSIR, ICMR, and the IITs. Similarly, on the other side, expertise in genomics was evolving, with Rosalind Franklin's X-ray images showing the DNA structure, Watson and Crick deciphering this structure, and early tools for reading it beginning to emerge. During the 1960s and 70s as India launched its space program, expanded higher education, and began investing in biotechnology, on the genomics front, Frederick Sanger, Allan Maxam, and Walter Gilbert developed methods to sequence DNA and genomics witnessed the birth of recombinant DNA technology giving way to the development of the first drug, human insulin, in 1982. The 1990s brought global integration for India. India's market was unlocked because of Economic liberalisation, unleashing new opportunities in IT, healthcare, and biotechnology. It was also a turning point in the genomics revolution with the launch of the Human Genome Project , aided by automated DNA sequencing and the mapping of disease-related genes. The project was aimed at identifying all the genes in human DNA and determining the sequences of the 3 billion base pairs that make up that DNA. The project took 13 years to complete. Its results opened doors to a new era of precision medicine and targeted disease management. In parallel, the dawn of the millennium also ushered in India as a global services hub. For Indian healthcare, this was also the era of several breakthroughs in clinical research and generics. The last couple of decades have been defined by leadership and innovation. India's digital revolution and the start-up boom showed the world its ability to lead in both scale and speed. In genomics, new technologies such as CRISPR genome editing and next-generation sequencing (NGS) have brought rapid improvements in throughput and cost, making NGS mainstream for research and clinical applications. Global quality genetic diagnostic tests, which can identify the root cause of complex diseases, are now available in India at affordable costs. High-end genetic tests developed in India and validated and backed by credible research stand testimony to India's scientific excellence, innovation, and talent, while also reiterating the country's commitment to its Make in India initiative. Population-scale projects like the Genome India Project aimed at sequencing one million genomes, a national effort by the Department of Biotechnology (DBT) to build a comprehensive reference genome for India, reflect India's contribution to advancing genomics, strengthening precision medicine and ensuring that genomics led early intervention and disease management are accessible to India's diverse and dynamic landscape. As we celebrate the 79th year of independent India, this reflection on India's remarkable journey in parallel with the journey of the source code of our life, our DNA, highlights not just the freedom of governance, but the freedom to have healthier, longer, and better lives. The article is written by Dr Venkataswamy Eswarachari, Senior Director, Lab Operations, MedGenome (DISCLAIMER: The views expressed are solely of the author and does not necessarily subscribe to it. shall not be responsible for any damage caused to any person/organisation directly or indirectly)
New Indian Express
3 days ago
- New Indian Express
Meet Giriraj Ratan Chandak, the scientist-cum-startup founder who serves through science
Tell us about your startup: what does it do, and what kind of impact are you hoping to make? I have had a deeply satisfying career at the Centre for Cellular and Molecular Biology. Yet, for a physician and scientist, the journey never truly ends. I realised there were many unfinished goals I still wished to pursue. To carry that vision forward, I founded a startup called Lightening Lives LLP. As the name suggests, the ethos is to 'light a lamp' in people's lives — whether by addressing genetic disorders, improving health, enabling treatments, or bringing hope in any possible way. Through this startup, our objective is to develop very simple, rapid, and affordable tests that can reach the most underserved sections of society. My years of work in genetic testing have confirmed that we are still only scratching the surface; with traditional approaches, barely 3–5% of patients undergo testing. The situation has only become more pressing with the rise of large-scale, high-throughput genetic testing, which often remains inaccessible to those who need it most. At Lightening Lives LLP, we decided to focus on 'commonly occurring rare diseases' such as thalassaemia, sickle cell anaemia, and muscular dystrophy, using simple, robust protocols. I am proud to say that along with CSIR-CCMB, we have developed a test for sickle cell anaemia that requires just a drop of blood and costs less than ₹100, making it possible to bring accurate diagnosis directly to the communities that need it most. We are on the path for doing the same for beta thalassemia.
